COVİD 19 PANDEMİSİNDE PLASENTA İNVAZYON ANOMALİSİ OLAN GEBEYE UTERUS KORUYUCU YAKLAŞIM

Yıl 2024, Cilt: 25 Sayı: 2, 257 – 259, 29.04.2024

Ceyda Karadağ Özer Birge , Mehmet Bakır , Ünzile Korkmaz Tayup Şimşek

https://doi.org/10.18229/kocatepetip.827098

Öz

Plasenta akreata spektrum bozukluğu (PAS) içinde yer alan plasenta akreata, inkreata ve perkreata insidansı, dünya çapında artan sezaryenle doğum oranlarına bağlı olarak artmaktadır. Primigravid gebelerde PAS insidansı %0.01 iken, uterus cerrahisi ve çok sayıda küretaj geçiren olgularda bu insidans belirgin olarak daha yüksektir. Bu invazyon anaomalileri yaşamı tehdit eden kanama ve buna bağlı masif kan tansfüzyonu nedeniyle annede morbidite ve mortaliteye neden olmakta ve acil histerektomi nedeniyle doğurganlık kaybına sebep olmaktadır. Covid 19 pandemisi ile mücadele edilen bu günlerde, PAS tanısı konulan olgulara konservatif yaklaşım oldukça büyük önem arz etmektedir. Bu olgu sunumunda, Covid 19 pandemisi döneminde konservatif cerrahi yöntemin tercih edildiği bir plasenta inkreata hastası tanımlanmıştır.

Anahtar Kelimeler

Covid 19, Plasenta invazyon anomalileri, Konservatif yaklaşım

Destekleyen Kurum

yok

Proje Numarası

yok

Kaynakça

• 1. Fox KA, Shamshirsaz AA, Carusi D, et al. Conservative management of morbidly adherent placenta: expert review. Am J Obstet Gynecol. 2015; 213(6): 755-60.
• 2. Solheim KN, Esakoff TF, Little SE, et al. Theeffect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality. J Matern Fetal Neonatal Med. 2011;24(11):1341-6.
• 3. Kean L. Antepartum Haemorrhage. In: Luesley DM, Kilby MD, Eds. Obstetrics & Gynaecology: An Evidence Based text for the MRCOG. 3rd ed. Boca Raton: Taylor and Francis, 2016;(3): 345-59.
• 4. Sheikh SM, Khair H. Conservative management of placenta accrete. Isra Med J. 2012;4:35-8.
• 5. Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand. 2011; 90(10):1140-6.
• 6. Sentilhes L, Kayem G, Silver R.M. Conservative Management of Placenta Accreta Spectrum. Clin Obstet Gynecol. 2018;61(4):783-94.
• 7. Silver RM, Kayem G, Sentilhes L. Placenta Accreta syndrome. Boca Raton: Taylor and Francis 2017.
• 8. Hunt JC. Conservative management of placenta accreta in a multiparous woman. J Pregnancy. 2010;(9):329618.
• 9. Wong SF, Chow KM, Leung TN, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191(1): 292-7.
• 10. Juan J, Gil M.M, Rong Z, et al. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review. Ultrasound Obstet Gynecol. 2020;56(1):15-27.

UTERUS PROTECTING APPROACH TO THE PREGNANCY WITH PLACENTAL INVASION ANOMALY IN COVID 19 PANDEMICS

Yıl 2024, Cilt: 25 Sayı: 2, 257 – 259, 29.04.2024

Ceyda Karadağ Özer Birge , Mehmet Bakır , Ünzile Korkmaz Tayup Şimşek

https://doi.org/10.18229/kocatepetip.827098

Öz

The incidence of placenta accreta, increta, and percreta, collectively called placenta accreta spectrum (PAS) disorders has been rising in the world due to the rise in the incidence of cesarean delivery. While the incidence of PAS disorders is 0.01% in primigravid pregnant women, its incidence increases significantly in women who have undergone numerous uterine surgeries and curettages. These invasion anomalies lead to maternal morbidity and mortality due to life threatening hemorrhage and related massive blood transfusion and cause fertility loss due to emergency hysterectomies. Conservative approach to these cases is extremely important in these days of struggle with the COVID 19 pandemic. This case report aims to describe the conservative surgical management of a placenta increata case during the Covid 19 pandemic.

Anahtar Kelimeler

Covid-19, Operative surgical procedures, Placenta Accreta

Proje Numarası

yok

Kaynakça

• 1. Fox KA, Shamshirsaz AA, Carusi D, et al. Conservative management of morbidly adherent placenta: expert review. Am J Obstet Gynecol. 2015; 213(6): 755-60.
• 2. Solheim KN, Esakoff TF, Little SE, et al. Theeffect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality. J Matern Fetal Neonatal Med. 2011;24(11):1341-6.
• 3. Kean L. Antepartum Haemorrhage. In: Luesley DM, Kilby MD, Eds. Obstetrics & Gynaecology: An Evidence Based text for the MRCOG. 3rd ed. Boca Raton: Taylor and Francis, 2016;(3): 345-59.
• 4. Sheikh SM, Khair H. Conservative management of placenta accrete. Isra Med J. 2012;4:35-8.
• 5. Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand. 2011; 90(10):1140-6.
• 6. Sentilhes L, Kayem G, Silver R.M. Conservative Management of Placenta Accreta Spectrum. Clin Obstet Gynecol. 2018;61(4):783-94.
• 7. Silver RM, Kayem G, Sentilhes L. Placenta Accreta syndrome. Boca Raton: Taylor and Francis 2017.
• 8. Hunt JC. Conservative management of placenta accreta in a multiparous woman. J Pregnancy. 2010;(9):329618.
• 9. Wong SF, Chow KM, Leung TN, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191(1): 292-7.
• 10. Juan J, Gil M.M, Rong Z, et al. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review. Ultrasound Obstet Gynecol. 2020;56(1):15-27.

Toplam 10 adet kaynakça vardır.

Ayrıntılar

Kaynak Göster

Download or read online: Click here